Multiple Assemblies exist for SMTL entry 5dsx
Crystal structure of Dot1L in complex with inhibitor CPD10 [6'-chloro-1,4-dimethyl-5'-(2-methyl-6-((4-(methylamino)pyrimidin-2-yl)amino)-1H-indol-1-yl)-[3,3'-bipyridin]-2(1H)-one]; X-RAY DIFFRACTION 2.41 Å

	SMTL ID 5dsx.1 Ligands POTASSIUM ION; 6'-chloro-1,4-dimethyl-5'-(2-methyl-6-{[4-(methylamino)pyrimidin-2-yl]amino}-1H-indol-1-yl)-3,3'-bipyridin-2(1H)-one Polypeptides Histone-lysine N-methyltransferase, H3 lysine-79 specific Oligo-state monomer
	SMTL ID 5dsx.2 Ligands POTASSIUM ION; 6'-chloro-1,4-dimethyl-5'-(2-methyl-6-{[4-(methylamino)pyrimidin-2-yl]amino}-1H-indol-1-yl)-3,3'-bipyridin-2(1H)-one Polypeptides Histone-lysine N-methyltransferase, H3 lysine-79 specific Oligo-state monomer